Vertex VERX 深 沪
已收盘 08-07 16:00:00 美东时间
11.94
+0.370
+3.20%
华盛通- 最 高12.69
- 今 开11.79
- 成交量 541.10万股
- 最 低 11.285
- 昨 收 11.57
- 总市值 177.91万
- 52周最高 26.625
- 市盈率 静 --
- 换手率 3631.57%
- 52周最低 10.21
- 委 比 61.05%
- 总股本 0.00亿
- 历史最高 60.71
- 量 比 1.70
- 振 幅 12.14%
- 历史最低 1.10
- 每 手 1
- 风险率 5.23%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Agios Reports Neutral Sickle Cell Data, Decides To Stop Development
Agios Pharmaceuticals stops tebapivat development in sickle cell disease after Phase 2 study fails to prove meaningful differentiation.
07-21 23:44
Nvidia, Vertex Pharmaceuticals And More On CNBC’s ‘Final Trades’
The Halftime Report Final Trades featured stock picks from Bryn Talkington, Jim Lebenthal, Liz Young Thomas, and Joseph M. Terranova.
07-09 19:45
Crude Oil Moves Higher; Rivian Automotive Shares Plunge
US stocks decline on Tuesday, with Nasdaq falling 0.61% and S&P 500 dropping 0.24%. Consumer staples shares rise 1.8% while tech stocks fall 2.1%. Logistics Manager's Index records strongest growth since March 2022.
07-08 01:06
Vertex Sees Over $5 Billion Peak Sales Potential From Crinetics Assets
Vertex to acquire Crinetics for $10 billion, adding approved acromegaly drug Palsonify and late-stage CAH candidate atumelnant to its rare disease portfolio.
07-07 20:24
Vertex Q1 Adj. EPS $0.17, Inline, Sales $196.646M Beat $194.827M Estimate
Vertex (NASDAQ:VERX) reported quarterly earnings of $0.17 per share which met the analyst consensus estimate. This is a 13.33 percent increase over earnings of $0.15 per share from the same period last year. The company
05-07 19:08
AI Tokens Vs. AI Stocks: Promises Vs. Profits
Artificial intelligence dominates market conversations, spawning two competing investment narratives. One rides on blockchain promises and decentralized computing dreams. The other ships actual chips, generates billions in profit, and pays real dividends. As we head toward 2026, the gap between AI cryptocurrency tokens and traditional AI stocks isn’t just wide.
2025-12-16 00:53
Monolithic Power, Ascendis Pharma And More: CNBC's 'Final Trades'
Amy Raskin, CIO at Chevy Chase Trust, named Ascendis Pharma (ASND) as her final trade on CNBC's Halftime Report. FDA extended review for TransCon CNP.
2025-12-09 21:16
Vertex's Gene Therapy Works In Children With Blood Disorders
Vertex Pharmaceuticals presents clinical data demonstrating benefits of Casgevy in SCD and TDT patients aged 5+ at ASH meeting.
2025-12-08 21:17
【招商策略】谷歌Nano Pro 实现专业级图像生成，Gemini 3测试突破-全球产业趋势跟踪周报
登录新浪财经APP 搜索【信披】查看更多考评等级 （来源：招商证券策略研究） 张夏 S1090513080006 李昊阳（产业趋势、主题投资...
2025-11-25 20:48
从对症治疗到根源突破，创新疗法开发如何为这类疾病患者带来新生？
编者按：囊性纤维化（CF）是一种家族遗传性疾状况，会对肺部、消化系统和身体其他器官造成严重损害。二十多年来，创新药的成功研发变革了囊性纤维化的治疗格局，显著提升...
2025-11-25 19:32
